The Non-Executive of CRH Medical (NYSE MKT: CRHM) is Buying Shares

By Carrie Williams

Today, the Non-Executive of CRH Medical (CRHMResearch Report), David Johnson, bought shares of CRHM for $9,600.

This is Johnson’s first Buy trade following 8 Sell transactions. Following this transaction David Johnson’s holding in the company was increased by 1% to a total of $740.9K.

See today’s analyst top recommended stocks >>

Currently, CRH Medical has an average volume of 75.81K. CRHM’s market cap is $138 million and the company has a P/E ratio of 76.40. The company has a one-year high of $4.43 and a one-year low of $0.86.

Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $3.29, reflecting a -41.6% downside. Four different firms, including Beacon and Canaccord Genuity, currently also have a Buy rating on the stock.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CRH Medical Corp. engages in the provision of gastroenterologists with services and products for the treatment of gastrointestinal diseases. It operates through the following business segments: Anesthesia Services, Product Sales, and Other. It also offers the CRH O’Regan System, which focuses on physician education, patient outcomes, and patient awareness. The Other segment covers the corporate activities. The company was founded in 2000 and is headquartered in Vancouver, Canada.